Showing results (391-400 of 465) with videos related to
Sort By:
Pageof 47
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cellsNayanendu Saha, Du-San Baek, Rachelle P Mendoza, et al.Journal of Immunological Methods|December 9, 2003
Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display libraryMei-Yun Zhang, Yuuei Shu, Sanjay Phogat, et al.Immunology and Cell Biology|March 8, 2005
Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1alpha responsesAndrew J Sloane, Vic Raso, Dimiter S Dimitrov, et al.Journal of Experimental & Clinical Cancer Research : CR|June 19, 2024
The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancerJiawei Zhang, Junjun Liu, Yali Yue, et al.Journal of Virology|May 3, 2014
Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodiesTianlei Ying, Lanying Du, Tina W Ju, et al.Viruses|May 27, 2023
A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic HenipavirusesMoushimi Amaya, Randy Yin, Lianying Yan, et al.Molecular and Cellular Endocrinology|September 18, 2012
Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signallingAimee J Varewijck, Michael P Brugts, Jan Frystyk, et al.Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120Chih-chin Huang, Miro Venturi, Shahzad Majeed, et al.Journal for Immunotherapy of Cancer|December 2, 2022
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapiesGuillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, et al.Energy & Environmental Science|January 10, 2017
Reduced voltage losses yield 10% efficient fullerene free organic solar cells with >1 V open circuit voltagesD Baran, T Kirchartz, S Wheeler, et al.Pageof 47